Detalhe da pesquisa
1.
Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Breast Cancer Res
; 21(1): 106, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31514736
2.
A multiparametric [18F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis.
Eur J Nucl Med Mol Imaging
; 46(9): 1878-1888, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31197455
3.
Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
J Magn Reson Imaging
; 49(3): 864-874, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30375702
4.
Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
J Magn Reson Imaging
; 50(3): 836-846, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811717
5.
Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization.
Cancers (Basel)
; 12(12)2020 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327532
6.
Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
Mol Imaging Biol
; 22(2): 453-461, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209778
7.
Histogram Analysis and Visual Heterogeneity of Diffusion-Weighted Imaging with Apparent Diffusion Coefficient Mapping in the Prediction of Molecular Subtypes of Invasive Breast Cancers.
Contrast Media Mol Imaging
; 2019: 2972189, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819738